DUBLIN--(BUSINESS WIRE)--Research and Markets (http://www.researchandmarkets.com/research/39prxd/global) has announced the addition of the "Global Hypertension Drug Pipeline Capsule - 2012 Update" report to their offering.
Fore Pharma's latest report Global Hypertension Drug Pipeline Capsule - 2012 Update provides most up-to-date information on key Research and Development activities (R&D) in the global Hypertension market. It covers active Hypertension pipeline molecules in various stages of clinical trials, preclinical research, and drug discovery.
This report helps executives track competitors pipeline molecules. The information presented in this report can be used for identifying partners, evaluating opportunities, formulating business development strategies, executing in-licensing and out-licensing deals.
The report provides information on pipeline molecules by company and mechanism of action across the R&D stages. It also provides information on pipeline molecules developed in leading geographies (North America and Europe). Licensing activities are thoroughly captured in this report.
Topics Covered:
1. Hypertension - Disease Overview
2. Hypertension Pipeline Overview
3. Hypertension Phase 3 Clinical Trial Pipeline Insights
4. Hypertension Phase 2 Clinical Trial Pipeline Insights
5. Hypertension Phase 1 Clinical Trial Pipeline Insights
6. Hypertension Preclinical Research Pipeline Insights
7. Hypertension Discovery Stage Pipeline Insights
8. Hypertension Drug Development Activities - Geographic Landscape
8.1. Hypertension R&D Activities in North America
8.2. Hypertension R&D Activities in Europe
9. Hypertension Pipeline - Licensing Activities
Table 1. Hypertension Pipeline Molecules - Phase 3 Clinical Trial
Table 2. Hypertension Pipeline Molecules - Phase 2 Clinical Trial
Table 3. Hypertension Pipeline Molecules - Phase 1 Clinical Trial
Table 4. Hypertension Pipeline Molecules - Preclinical Research
Table 5. Hypertension Pipeline Molecules - Drug Discovery
Table 6. Hypertension R&D Activities by Geography
Table 7. Hypertension Pipeline Molecules - North America
Table 8. Hypertension Pipeline Molecules - Europe
Table 9. Hypertension Pipeline - Licensing Activities
Figure 1. Hypertension Pipeline Molecules by R&D Stage
Figure 2. Hypertension R&D Activities by Geography
For more information visit http://www.researchandmarkets.com/research/39prxd/global